Metraipolis › archive › dc_c77cb7bd0690

Real-world study of adverse events associated with sodium zirconium cyclosilicate based on FDA adverse event reporting system and VigiAccess database — Europe PMC PMID:41071822

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41071822
DOI
10.1371/journal.pone.0333692
License (as archived)
solo-consultazione
Archived
2026-11-09T10:27:07.178Z
SHA-256 of the archived text
28b6c5f4ddc4344c4bc7d2404362b496b48660e0b24e2ceb0c7ddf4ef5773fa9
Stable URL of this page
https://metraipolis.com/documento/dc_c77cb7bd0690

How to cite

Real-world study of adverse events associated with sodium zirconium cyclosilicate based on FDA adverse event reporting system and VigiAccess database — Europe PMC PMID:41071822 — Europe PMC (en), https://europepmc.org/article/MED/41071822 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c77cb7bd0690 (Metraipolis archive dc_c77cb7bd0690, sha256 28b6c5f4ddc4344c4bc7d2404362b496b48660e0b24e2ceb0c7ddf4ef5773fa9)
BibTeX
@misc{dcc77cb7bd0690,
  title = {Real-world study of adverse events associated with sodium zirconium cyclosilicate based on FDA adverse event reporting system and VigiAccess database — Europe PMC PMID:41071822},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41071822},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c77cb7bd0690; sha256 28b6c5f4ddc4344c4bc7d2404362b496b48660e0b24e2ceb0c7ddf4ef5773fa9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41071822. Agents can read the archived copy with the MCP tool read_document.